Benlysta starts working right away, but it may take time for you to see improvements in your symptoms. Some people started to see improvements after 8 weeks. Benlysta starts working right away ...
GlaxoSmithKline’s Benlysta has been on the market for almost a decade, but it still has some tricks up its sleeve – it’s just become the first and only FDA-approved treatment for lupus ...
It is notoriously hard to treat effectively. Saphnelo will compete in the market most closely with GlaxoSmithKline's BLyS inhibitor Benlysta (belimumab), which has been available in the EU to ...
A recent integrated analysis of five randomised clinical trials of belimumab has reinforced the significance of serological markers in treating systemic lupus erythematosus (SLE) using a ...
Objectives To evaluate the efficacy and safety of belimumab, targeting BAFF, in patients with pSS. Methods Patients were included in this bi-centric prospective 1-year open-label trial if they ...
EULAR recommendations for the management of Sjögren’s syndrome with topical and systemic therapies
abatacept and belimumab). For each recommendation, levels of evidence (mostly modest) and TF agreement (mostly very high) are provided. The 2019 EULAR recommendations are based on the evidence ...
belimumab administered within 12 weeks prior to screening. III) any B cell-depleting therapies, other than ianalumab administered within 36 weeks prior to randomization or as long as B cell count is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback